Table 3. CM and Cox regression estimates of survival for study, presence of metastases at diagnosis, pelvic involvement and age.

Model	Estimate	s.e.	z	P-value
CM II
Intercept	−0.224	0.168	−1.33	0.183
Study
ET-1	0
ET-2	−0.809	0.142	−5.71	<0.001
Metastases
No	0
Yes	0.878	0.167	5.27	<0.001
Pelvic
No	0
Yes	0.566	0.160	3.55	<0.001
Age ⩾10
No	0
Years
Yes	0.314	0.171	1.84	0.065
Scale
log λ	−1.448	0.066	−21.93	<0.001
λ	0.23
Shape
log γ	0.330	0.051	6.53	<0.001
γ	1.39
CM III
Intercept	−0.263	0.175	−1.51	0.132
Study
ET-1	0
ET-2	−0.904	0.154	−5.86	<0.001
Metastases
No	0
Yes	0.875	0.197	4.44	<0.001
Pelvic
No	0
Yes	0.614	0.178	3.45	0.001
Age ⩾10
No	0
Years
Yes	0.426	0.180	2.37	0.018
Scale
Intercept	−1.305	0.150	−8.72	<0.001
Study
ET-1	0
ET-2	0.267	0.130	2.05	0.041
Metastases
No	0
Yes	−0.069	0.244	−0.28	0.778
Pelvic
No	0
Yes	0.056	0.177	0.32	0.750
Age ⩾10
No	0
Years
Yes	−0.338	0.148	−2.28	0.023
Shape
Intercept	0.230	0.121	2.47	0.013
Study
ET-1	0
ET-2	0.135	0.110	1.23	0.218
Metastases
No	0
Yes	−0.116	0.175	−0.66	0.507
Pelvic
No	0
Yes	0.249	0.172	1.45	0.147
Age ⩾10
No	0
Years
Yes	−0.041	0.128	−0.32	0.750
Cox II
Study
ET-1	0
ET-2	−0.740	0.143	−5.18	<0.001
Metastases
No	0
Yes	0.861	0.166	5.17	<0.001
Pelvic
No	0
Yes	0.540	0.160	3.39	0.0007
Age ⩾10
No	0
Years
Yes	0.297	0.170	1.74	0.0819